The expression of the NR1-subunit of the NMDA receptor during mouse and early chicken development

Gregory D Bennett1, Kristine Moser, Tammy Chaudoin

  • 1Department of Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, 985805 UNMC, Omaha, NE 68198-5805, USA. gbennett@unmc.edu

Insights

Homocysteine may cause birth defects by inhibiting the N-methyl-D-aspartate (NMDA) receptor. Mouse embryos lack NMDA receptor expression during early development, unlike chicks, suggesting a species-specific susceptibility to homocysteine-induced defects.

Area of Science:

  • Developmental biology
  • Neuroscience
  • Teratology

Background:

  • Homocysteine-induced defects are hypothesized to involve N-methyl-D-aspartate (NMDA) receptor inhibition.
  • Previous studies primarily used chicken embryos, with limited success in establishing murine models.

Purpose of the Study:

  • Investigate the ontogeny of the NMDA receptor in mouse and chicken embryos.
  • Understand species-specific differences in susceptibility to homocysteine-induced defects.

Main Methods:

  • Western blot analysis for NR1-subunit protein expression in both species.
  • RT-PCR for temporal NR1-subunit transcript expression in murine embryos (gestational days 8.5-18.5).

Main Results:

  • NMDA receptor expression detected early in chick embryo development.
  • Neither NR1-subunit transcript nor protein was detected in mouse embryos during early neurulation and heart development.
  • NR1-subunit expression became detectable in mouse embryos around gestational days 14.5-15.5, increasing until term.

Conclusions:

  • The delayed expression of the NMDA receptor's NR1-subunit in mice correlates with their lower susceptibility to homocysteine-induced defects.
  • These findings suggest that the NMDA receptor plays a role in mediating homocysteine-induced developmental abnormalities.

Related Concept Videos